0001104659-20-004326.txt : 20200115
0001104659-20-004326.hdr.sgml : 20200115
20200115161518
ACCESSION NUMBER: 0001104659-20-004326
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200115
DATE AS OF CHANGE: 20200115
EFFECTIVENESS DATE: 20200115
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-358165
FILM NUMBER: 20528439
BUSINESS ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 781-788-9043
MAIL ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
D
1
primary_doc.xml
X0708
D
LIVE
0001372514
EYEGATE PHARMACEUTICALS INC
271 WAVERLEY OAKS ROAD
SUITE 108
WALTHAM
MA
MASSACHUSETTS
02452
781-788-9043
DELAWARE
None
None
Corporation
true
Stephen
From
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Executive Officer
Director
Sarah
Romano
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Executive Officer
Bernard
Malfroy-Camine
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Paul
Chaney
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Steven
Boyd
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Morton
Goldberg
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Praveen
Tyle
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Thomas
Hancock
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Keith
Maher
271 Waverley Oaks Road, Suite 108
Waltham
MA
MASSACHUSETTS
02452
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-01-03
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVE.
3RD FLOOR
NEW YORK
NY
NEW YORK
10022
NJ
NEW JERSEY
NY
NEW YORK
false
Indefinite
0
Indefinite
This Form D is being filed in connection with warrants issued to H.C. Wainwright & Co., LLC as partial compensation with a registered direct offering by the Issuer.
false
5
0
0
H.C. Wainwright & Co., LLC received warrants to purchase 25,000 shares of common stock of the Issuer in connection with a registered direct offering by the Issuer on January 3, 2020, among other compensation.
0
false
EYEGATE PHARMACEUTICALS INC
/s/ Stephen From
Stephen From
President and CEO
2020-01-15